跳至主要内容
临床试验/KCT0001967
KCT0001967尚未招募未知

Effect of gyejibongneyong-hwan for treatment of dysmenorrhea of uterine fibroids caused by blood stasis: A double blind, randomized placebo controlled trial

Korea Institute of Oriental Medicine0 个研究点目标入组 38 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 45(Year)(—)
性别
Female

入选标准

  • 1.Females between 18 and 45 years of age and diagnosed with Blood stasis syndrome.
  • 2.Females diagnosed blood stasis through screening test at gynecology
  • 3.Confirmation of uterine myomas by ultrasonography (over 2 cm).
  • 4.Provide written informed consent to participate in the study.
  • 5.Agree to comply with the study regulations.

排除标准

  • 1. Patients with heart disease, liver disease, kidney disease or any psychiatric condition.
  • 2. Patients who are unable to communicate or are critically ill.
  • 3. Pregnant women.
  • 5. Patients who take regular medication, including serotonin, anti-depressants, or other anti-psychiatric drugs.
  • 4. Patients with any condition that could influence the study assessment.

研究者

相似试验